Brain inflammation caused by chronic nerve pain alters activity in regions that regulate mood and motivation, suggesting for the first time that a direct biophysical link exists between long-term pain and the depression, anxiety and substance abuse seen in more than half of these patients, UC Irvine and UCLA researchers report. The opensource study is published in the Journal of Neuroscience.
The team state that the data findings also points to new approaches for treating chronic pain, which is second only to bipolar disorder among illness-related causes of suicide. About a quarter of Americans suffer from chronic pain, making it the most common form of enduring illness for those under the age of 60. The Institute of Medicine estimates that this costs the US economy more than $635 billion per year.
Using rodent animal models over five-years the team discovered that pain-derived brain inflammation causes the accelerated growth and activation of immune cells called microglia. These cells trigger chemical signals within neurons that restrict the release of dopamine, a neurotransmitter that helps control the brain’s reward and pleasure centers. The results also show why opioid drugs such as morphine can be ineffective against chronic pain. Previous studies show that morphine and its derivatives normally stimulate the release of dopamine. However, the current study showed that these drugs failed to stimulate a dopamine response, resulting in impaired reward-motivated behavior.
The team found that treating these animals in chronic pain with a drug that inhibits microglial activation restored dopamine release and reward-motivated behavior.
The researchers state that for over 20 years, scientists have been trying to unlock the mechanisms at work that connect opioid use, pain relief, depression and addiction. The team note that the current study represents a paradigm shift which has broad implications that are not restricted to the problem of pain and may translate to other disorders.
Next, the team aim to establish that pain-derived changes in human brain circuitry can account for mood disorders. The lab state that they have a drug compound that has the potential to normalize reward-like behaviour and plan to employ imaging studies to identify how the same disruption in reward circuitry found in rodents occurs in chronic pain patients.
Source: University of California, Irvine
Michelle Petersen is the founder of Healthinnovations, having worked in the health and science industry for over 21 years, which includes tenure within the NHS and Oxford University. Healthinnovations is a publication that has reported on, influenced, and researched current and future innovations in health for the past decade.
Michelle has been picked up as an expert writer for Informa publisher’s Clinical Trials community, as well as being listed as a blog source by the world’s leading medical journals, including the acclaimed Nature-Springer journal series.
Healthinnovations is currently indexed by the trusted Altmetric and PlumX metrics systems, respectively, as a blog source for published research globally. Healthinnovations is also featured in the world-renowned BioPortfolio, BioPortfolio.com, the life science, pharmaceutical and healthcare portal.
Most recently the Texas A&M University covered The Top 10 Healthinnovations series on their site with distinguished Professor Stephen Maren calling the inclusion of himself and his team on the list a reflection of “the hard work and dedication of my students and trainees”.
Michelle Petersen’s copy was used in the highly successful marketing campaign for the mega-hit film ‘Jumanji: The Next Level, starring Jack Black, Karen Gilian, Kevin Hart and Dwayne ‘The Rock’ Johnson. Michelle Petersen’s copywriting was part of the film’s coverage by the Republic TV network. Republic TV is the most-watched English language TV channel in India since its inception in 2017.
An avid campaigner in the fight against child sex abuse and trafficking, Michelle is a passionate humanist striving for a better quality of life for all humans by helping to provide traction for new technologies and techniques within healthcare.